ERBB2 and breast cancer: In conclusion, our calculations show that these two prognostic indices, NPI and API, are only reliable tools when applied to breast cancer cases, that are of no special type, NST (WHO 8500/3), estrogen receptor-positive, Her2-negative and when affected women are ≤70 years old.